Regeneron Pharmaceuticals shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and announced a $750 price target.

by | Dec 9, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.